Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

938
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
938
Drug Therapy01:28

Drug Therapy

416
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
416
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

680
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
680
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

1.0K
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
1.0K
Personality Disorders: Paranoid and Schizoid01:22

Personality Disorders: Paranoid and Schizoid

1.1K
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renewed mandate for Schools of Public Health: a call to action.

BMJ public health·2026
Same author

Comparative effectiveness and safety of pharmacological treatments for rapid tranquilisation in emergency settings: a systematic review and individual participant data network meta-analysis.

The lancet. Psychiatry·2026
Same author

Call to action: building a better future together, powered by evidence, guided by collective impact.

The Cochrane database of systematic reviews·2025
Same author

Rapid tranquillisation for psychiatric in-patients with a diagnosis of personality disorder: under-recognised issue.

BJPsych open·2025
Same author

Improving the clinical trial environment and infrastructure: moving from global resolution to action.

The Lancet. Global health·2025
Same author

Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocol.

JBI evidence synthesis·2025
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.5K

Supportive therapy for schizophrenia.

Lucy A Buckley1, Nicola Maayan, Karla Soares-Weiser

  • 1Sunderland Psychotherapy Service, Northumberland, Tyne and Wear NHS Foundation Trust, Cherry Knowle Hospital, Upper Poplars, Ryhope, Sunderland, Tyne and Wear, UK, SR2 0NB.

The Cochrane Database of Systematic Reviews
|April 15, 2015
PubMed
Summary
This summary is machine-generated.

Supportive therapy shows no significant difference compared to standard care for schizophrenia. However, other psychological therapies may offer advantages, though evidence quality is very low.

More Related Videos

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

911

Related Experiment Videos

Last Updated: Apr 15, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.5K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

911

Area of Science:

  • Psychiatry and Mental Health Research
  • Clinical Trials and Evidence Synthesis

Background:

  • Supportive therapy is a common clinical practice for individuals with schizophrenia.
  • Its efficacy is often evaluated against standard care or as an adjunct to other treatments.

Purpose of the Study:

  • To compare the effects of supportive therapy against standard care for schizophrenia.
  • To assess supportive therapy in addition to standard care versus other treatments for schizophrenia.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
  • Searched the Cochrane Schizophrenia Group register up to November 2012, including 24 RCTs with 2126 participants.
  • Data were analyzed using fixed-effect models, assessing risk ratios and mean differences, with heterogeneity and publication bias evaluated.

Main Results:

  • No significant differences were found in relapse, hospitalization, or general functioning between supportive therapy and standard care.
  • Other psychological/psychosocial therapies showed potential advantages over supportive therapy in hospitalization rates and mental state improvement, but evidence quality was very low.
  • Comparisons with cognitive behavioral therapy, family therapy, and psychoeducation yielded no significant differences in primary outcomes due to limited data.

Conclusions:

  • Insufficient evidence exists to differentiate supportive therapy from standard care for schizophrenia outcomes.
  • While some psychological therapies may be more effective, findings are based on limited, low-quality studies.
  • Future research should focus on larger trials where supportive therapy is the primary intervention studied.